AbbVie 2013 Annual Report Download - page 102

Download and view the complete annual report

Please find page 102 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

Note 15 Quarterly Financial Data (unaudited)
(in millions except per share data) 2013 2012
First Quarter
Net sales $4,329 $4,173
Gross margin 3,176 3,017
Net earnings 968 883
Basic earnings per share 0.61 0.56
Diluted earnings per share 0.60 0.56
Cash dividends declared per common share(a) 0.80
Second Quarter
Net sales $4,692 $4,493
Gross margin 3,638 3,420
Net earnings 1,068 1,267
Basic earnings per share 0.67 0.80
Diluted earnings per share 0.66 0.80
Cash dividends declared per common share 0.40
Third Quarter
Net sales $4,658 $4,508
Gross margin 3,566 3,494
Net earnings 964 1,585
Basic earnings per share 0.60 1.01
Diluted earnings per share 0.60 1.01
Cash dividends declared per common share 0.40
Fourth Quarter
Net sales $5,111 $5,206
Gross margin 3,829 3,941
Net earnings 1,128 1,540
Basic earnings per share 0.70 0.98
Diluted earnings per share 0.70 0.98
Cash dividends declared per common share 0.40
(a) On January 4, 2013, the board of directors declared a cash dividend of $0.40 per share of common
stock. This dividend was declared from pre-separation earnings and was recorded as a reduction of
additional paid-in capital. In addition, AbbVie declared regular quarterly cash dividends in 2013
aggregating $1.60 per share of common stock. Refer to Note 11 for information regarding cash
dividends declared in 2013.
For periods prior to the separation, the weighted-average basic and diluted shares outstanding was
based on the number of shares of AbbVie common stock outstanding on the distribution date. Refer to
Note 4 for information regarding the calculation of basic and diluted earnings per common share for
the year ended December 31, 2013.
98